![]() |
市場調查報告書
商品編碼
2024750
泌尿系統機器人手術市場分析:按組件、應用和地區分類(2026-2034 年)Urology Robotic Surgery Market Report by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2026-2034 |
||||||
2025年,全球泌尿系統泌尿外科手術市場規模達21億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到45億美元,2026年至2034年的複合年成長率為8.36%。市場成長的主要促進因素是骨退化性疾病和腎臟/泌尿系統疾病(尤其是在老年族群)的盛行率不斷上升,以及膝關節和髖關節置換術中對微創輔助手術的需求不斷成長。
泌尿系統泌尿外科手術是一種微創治療方法,它使用微型化的電腦控制機械手臂和配備攝影機及人工感測裝置的手術器械。這些器械透過微小的穿刺口而非較大的切口插入,在醫務人員透過各種機器人主機的監控下,能夠到達偏遠和關鍵區域,並提供手術區域清晰的3D(3D)影像。標準配備包括機器人本體、導航系統、模擬器、手術規劃器和其他必要的配件。泌尿系統泌尿外科手術能夠實現精準的運動和高倍放大視野,最大限度地提高手術效率,同時確保手術過程中醫務人員之間的協作,並最大限度地減少恢復時間、出血量和術後併發症。此外,它還能減少疤痕、疼痛、不適和感染風險,從而縮短住院時間並改善臨床療效。因此,機器人泌尿系統手術已廣泛應用於醫院和診所,用於根治性攝護腺切除術、根治性膀胱切除術、腎切除術和腎盂成形術等手術。
腎臟和泌尿系統疾病的日益普遍是市場成長的主要驅動力。老年人口的成長,尤其是老年人更容易罹患這些疾病,也促進了市場成長。因此,由於微創輔助膝關節和髖關節置換術手術相比傳統手術具有許多優勢,其需求不斷成長,這也是另一個成長促進因素。此外,對能夠顯著降低人為錯誤可能性的自動化手術器械的需求不斷成長,也推動了市場成長。將機器人輔助軟性內視鏡整合到系統中,使醫療專業人員能夠接觸和治療複雜的解剖結構,並提高診斷程序的準確性,這也推動了市場成長。此外,基於軟體的遠端運動控制(RCM)和具有複雜運動控制功能的模組化機器人手術系統的出現,正在加速市場成長。此外,為製造更有效率的泌尿系統手術機器人而進行的持續研發活動,以及手術介入產品多樣化的進展,都為市場創造了良好的前景。醫療保健預算的增加和醫療基礎設施的改善等其他因素也在推動市場成長。
The global urology robotic surgery market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.36% during 2026-2034. The increasing prevalence of bone degenerative and kidney or urinary tract diseases, especially amongst the geriatric population, along with the rising demand for minimally invasive assisted surgeries for knee and hip replacements, represent some of the key factors driving the market.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computer-controlled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
This report provides an analysis of the key trends in each segment of the global urology robotic surgery market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on component and application.
The report has also provided a detailed breakup and analysis of urology robotic surgery market based on the component. This includes robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the largest segment.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology robotic surgery. Some of the factors driving the North America urology robotic surgery market included the increasing prevalence of kidney and urinary tract diseases and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global urology robotic surgery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.